Cost-effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

Research output: Contribution to journal › Article › Academic › peer-review

263 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1800-1806
Number of pages	7
Journal	New England Journal of Medicine
Volume	346
DOIs	https://doi.org/10.1056/NEJM200206063462309
Publication status	Published - 2002

Research programs

@article{b6d09a92a4c040398d6a57b1cb5ee973,

title = "Cost-effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.",

author = "JM Gaspoz and PG Coxson and PA Goldman and LW Williams and KM Kuntz and Myriam Hunink and L Goldman",

year = "2002",

doi = "10.1056/NEJM200206063462309",

language = "Undefined/Unknown",

volume = "346",

pages = "1800--1806",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

}

TY - JOUR

T1 - Cost-effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

AU - Gaspoz, JM

AU - Coxson, PG

AU - Goldman, PA

AU - Williams, LW

AU - Kuntz, KM

AU - Hunink, Myriam

AU - Goldman, L

PY - 2002

Y1 - 2002

U2 - 10.1056/NEJM200206063462309

DO - 10.1056/NEJM200206063462309

M3 - Article

SN - 0028-4793

VL - 346

SP - 1800

EP - 1806

JO - New England Journal of Medicine

JF - New England Journal of Medicine

ER -